One-Year Outcomes After Belatacept Conversion in Adolescent Kidney Transplant Recipients

One-Year Outcomes After Belatacept Conversion in Adolescent Kidney Transplant Recipients

Introduction: Belatacept (CTLA4-Ig) has shown efficacy in adult kidney transplantation (KT) recipients (improved graft and patient survival and reduced de novo donor-specific antibody [DSA]) compared with calcineurin inhibitors (CNIs). Its long-term benefits and monthly i.v. administration have rais...

Full description

Saved in:
Bibliographic Details
Main Authors: Charlotte Duneton, Roshan George, Rochelle Liverman, Anne-Laure Sellier-Leclerc, Beatrice Beauval, Véronique Baudouin, Elodie Cheyssac, Barry Warshaw, Julien Hogan, Rouba Garro
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Kidney International Reports
Subjects:
belatacept
costimulation blockade
kidney transplantation
outcomes
pediatrics
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024925001597
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2468024925001597

Similar Items